|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940 |
|
| ||||||||||||||||||||||||||||||||||||||
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | |||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. | SEC 1474 (9-02) |
1. Title of Derivative Security (Instr. 3) |
2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) | 4. Transaction Code (Instr. 8) |
5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) |
6. Date Exercisable and Expiration Date (Month/Day/Year) |
7. Title and Amount of Underlying Securities (Instr. 3 and 4) |
8. Price of Derivative Security (Instr. 5) |
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) |
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) |
11. Nature of Indirect Beneficial Ownership (Instr. 4) |
||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
Stock Option (2) | (3) | 08/20/2018 | M | 16,385 | (4) | (5) | Common Stock | 16,385 | $ 0 | 107,267 (6) | D |
Reporting Owner Name / Address | Relationships | |||
Director | 10% Owner | Officer | Other | |
David Glenn C/O ZOETIS INC. 10 SYLVAN WAY PARSIPPANY, NJ 07054 |
Chief Financial Officer |
/s/ Katherine H. Walden, as Attorney-in-Fact | 08/21/2018 | |
**Signature of Reporting Person | Date |
* | If the form is filed by more than one reporting person, see Instruction 4(b)(v). |
** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
(1) | The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $92.09 to $92.31, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
(2) | Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant. |
(3) | 16,385 options granted March 4, 2014 at an exercise price of $30.89 per option. |
(4) | Each option vests on the third anniversary of the date of grant. |
(5) | Each option expires on the tenth anniversary of the date of grant. |
(6) | 7,712 options granted February 27, 2015 at an exercise price of $46.09 per option; 8,191 options granted February 19, 2016 at an exercise price of $41.83; 21,301 options granted August 22, 2016 at an exercise price of $51.23 per option; 11,144 options granted December 6, 2016 at an exercise price of $50.22 per option; 32,634 options granted February 14, 2017 at an exercise price of $55.02 per option; and 26,285 options granted February 13, 2018 at an exercise price of $73.24 per option. |